Johnson & Johnson
-
Business
Missouri finalizes $458M deal in opioid epidemic lawsuit
COLUMBIA, Mo. (AP) — Missouri will get $458 million to help victims of the opioid epidemic as part of a…
Read More » -
Coronavirus
CDC panel backs expanded COVID-19 booster rollout
WASHINGTON (AP) — Millions more Americans are closer to getting a COVID-19 booster as influential government advisers endorsed on Thursday…
Read More » -
Coronavirus
County will use Pfizer to replace J&J vaccine; plenty of doses available
ST. LOUIS COUNTY • County Executive Sam Page said that pausing the Johnson & Johnson (J&J) vaccine was the right thing…
Read More » -
Coronavirus
Pause for J&J vaccine extended as federal health panel wrestles with next steps
WASHINGTON — Use of the Johnson & Johnson COVID-19 shot will remain paused for at least a week, after a federal…
Read More » -
Coronavirus
Missouri pausing use of Johnson & Johnson vaccine
Missouri will pause use of the Johnson & Johnson vaccine as recommended by federal authorities who are investigating six instances…
Read More » -
Coronavirus
No immediate impact in Missouri from J&J vaccine problem
JEFFERSON CITY (AP) — The loss of up to 15 million doses of Johnson & Johnson’s COVID-19 vaccine due to…
Read More » -
Coronavirus
J&J vaccinations to start Wednesday in Missouri
(AP) — Missouri vaccinators are expected to receive the first 50,000 doses of the newly approved Johnson & Johnson COVID-19…
Read More » -
Business
J&J’s vaccine is cleared, giving U.S. third COVID-19 weapon
WASHINGTON (AP) — The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration cleared…
Read More » -
Coronavirus
Advisers endorse single-shot COVID-19 vaccine from J&J
WASHINGTON (AP) — U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the…
Read More » -
Coronavirus
More COVID-19 vaccines in pipeline
A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies…
Read More »
